BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33632293)

  • 1. Clinical-grade whole-genome sequencing and 3' transcriptome analysis of colorectal cancer patients.
    Stodolna A; He M; Vasipalli M; Kingsbury Z; Becq J; Stockton JD; Dilworth MP; James J; Sillo T; Blakeway D; Ward ST; Ismail T; Ross MT; Beggs AD
    Genome Med; 2021 Feb; 13(1):33. PubMed ID: 33632293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
    Mogensen MB; Rossing M; Østrup O; Larsen PN; Heiberg Engel PJ; Jørgensen LN; Hogdall EV; Eriksen J; Ibsen P; Jess P; Grauslund M; Nielsen HJ; Nielsen FC; Vainer B; Osterlind K
    BMC Cancer; 2018 Jul; 18(1):752. PubMed ID: 30029640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer.
    Shanmugam V; Ramanathan RK; Lavender NA; Sinari S; Chadha M; Liang WS; Kurdoglu A; Izatt T; Christoforides A; Benson H; Phillips L; Baker A; Murray C; Hostetter G; Von Hoff DD; Craig DW; Carpten JD
    BMC Med Genomics; 2014 Jun; 7():36. PubMed ID: 24943349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer.
    Gambaro K; Marques M; McNamara S; Couetoux du Tertre M; Diaz Z; Hoffert C; Srivastava A; Hébert S; Samson B; Lespérance B; Ko YJ; Dalfen R; St-Hilaire E; Sideris L; Couture F; Burkes R; Harb M; Camlioglu E; Gologan A; Pelsser V; Constantin A; Greenwood CMT; Tejpar S; Kavan P; Kleinman CL; Batist G
    Clin Transl Med; 2021 Apr; 11(4):e401. PubMed ID: 33931971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.
    Li X; Kumar S; Harmanci A; Li S; Kitchen RR; Zhang Y; Wali VB; Reddy SM; Woodward WA; Reuben JM; Rozowsky J; Hatzis C; Ueno NT; Krishnamurthy S; Pusztai L; Gerstein M
    Genome Med; 2021 Apr; 13(1):70. PubMed ID: 33902690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
    Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
    Elife; 2020 May; 9():. PubMed ID: 32401198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors.
    Wang R; Li J; Zhou X; Mao Y; Wang W; Gao S; Wang W; Gao Y; Chen K; Yu S; Wu X; Wen L; Ge H; Fu W; Tang F
    Genome Med; 2022 Aug; 14(1):93. PubMed ID: 35974387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing.
    Mansukhani S; Barber LJ; Kleftogiannis D; Moorcraft SY; Davidson M; Woolston A; Proszek PZ; Griffiths B; Fenwick K; Herman B; Matthews N; O'Leary B; Hulkki S; Gonzalez De Castro D; Patel A; Wotherspoon A; Okachi A; Rana I; Begum R; Davies MN; Powles T; von Loga K; Hubank M; Turner N; Watkins D; Chau I; Cunningham D; Lise S; Starling N; Gerlinger M
    Clin Chem; 2018 Nov; 64(11):1626-1635. PubMed ID: 30150316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
    Ross JS; Fakih M; Ali SM; Elvin JA; Schrock AB; Suh J; Vergilio JA; Ramkissoon S; Severson E; Daniel S; Fabrizio D; Frampton G; Sun J; Miller VA; Stephens PJ; Gay LM
    Cancer; 2018 Apr; 124(7):1358-1373. PubMed ID: 29338072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.
    Vignot S; Lefebvre C; Frampton GM; Meurice G; Yelensky R; Palmer G; Capron F; Lazar V; Hannoun L; Miller VA; André F; Stephens PJ; Soria JC; Spano JP
    Eur J Cancer; 2015 May; 51(7):791-9. PubMed ID: 25797355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response.
    Temko D; Van Gool IC; Rayner E; Glaire M; Makino S; Brown M; Chegwidden L; Palles C; Depreeuw J; Beggs A; Stathopoulou C; Mason J; Baker AM; Williams M; Cerundolo V; Rei M; Taylor JC; Schuh A; Ahmed A; Amant F; Lambrechts D; Smit VT; Bosse T; Graham TA; Church DN; Tomlinson I
    J Pathol; 2018 Jul; 245(3):283-296. PubMed ID: 29604063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-read sequencing identifies novel structural variations in colorectal cancer.
    Xu L; Wang X; Lu X; Liang F; Liu Z; Zhang H; Li X; Tian S; Wang L; Wang Z
    PLoS Genet; 2023 Feb; 19(2):e1010514. PubMed ID: 36812239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer.
    Guo Y; Guo XL; Wang S; Chen X; Shi J; Wang J; Wang K; Klempner SJ; Wang W; Xiao M
    Oncologist; 2020 Nov; 25(11):e1671-e1680. PubMed ID: 32627883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genomic landscape of response to EGFR blockade in colorectal cancer.
    Bertotti A; Papp E; Jones S; Adleff V; Anagnostou V; Lupo B; Sausen M; Phallen J; Hruban CA; Tokheim C; Niknafs N; Nesselbush M; Lytle K; Sassi F; Cottino F; Migliardi G; Zanella ER; Ribero D; Russolillo N; Mellano A; Muratore A; Paraluppi G; Salizzoni M; Marsoni S; Kragh M; Lantto J; Cassingena A; Li QK; Karchin R; Scharpf R; Sartore-Bianchi A; Siena S; Diaz LA; Trusolino L; Velculescu VE
    Nature; 2015 Oct; 526(7572):263-7. PubMed ID: 26416732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer.
    Mamlouk S; Childs LH; Aust D; Heim D; Melching F; Oliveira C; Wolf T; Durek P; Schumacher D; Bläker H; von Winterfeld M; Gastl B; Möhr K; Menne A; Zeugner S; Redmer T; Lenze D; Tierling S; Möbs M; Weichert W; Folprecht G; Blanc E; Beule D; Schäfer R; Morkel M; Klauschen F; Leser U; Sers C
    Nat Commun; 2017 Jan; 8():14093. PubMed ID: 28120820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features.
    Mendelaar PAJ; Smid M; van Riet J; Angus L; Labots M; Steeghs N; Hendriks MP; Cirkel GA; van Rooijen JM; Ten Tije AJ; Lolkema MP; Cuppen E; Sleijfer S; Martens JWM; Wilting SM
    Nat Commun; 2021 Jan; 12(1):574. PubMed ID: 33495476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of
    Owen DR; Wong HL; Bonakdar M; Jones M; Hughes CS; Morin GB; Jones SJM; Renouf DJ; Lim H; Laskin J; Marra M; Yip S; Schaeffer DF
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29438965
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
    Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy.
    Harada K; Okamoto W; Mimaki S; Kawamoto Y; Bando H; Yamashita R; Yuki S; Yoshino T; Komatsu Y; Ohtsu A; Sakamoto N; Tsuchihara K
    BMC Cancer; 2019 Mar; 19(1):255. PubMed ID: 30898102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.